Are you Dr. Bonner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
12680 Olive Blvd
Ste 200
Saint Louis, MO 63141Phone+1 314-251-8892Fax+1 314-251-8894- Is this information wrong?
Summary
- Dr. Jo Bonner, MD is a board certified neurologist in Saint Louis, Missouri. She is currently licensed to practice medicine in Missouri and Ohio. She is affiliated with Mercy Hospital St. Louis.
Education & Training
St Louis University School of MedicineResidency, Neurology, 1990 - 1991
University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 1988 - 1990
University of Missouri-ColumbiaResidency, Neurology, 1987 - 1988- University of Missouri-ColumbiaResidency, Internal Medicine, 1985 - 1987
University of Missouri-Columbia School of MedicineClass of 1985
Certifications & Licensure
MO State Medical License 1985 - 2025
OH State Medical License 1988 - 1994- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07
- A Study of Galcanezumab in Participants With Chronic Cluster Headache Start of enrollment: 2015 Jun 18
Publications & Presentations
PubMed
- 9 citationsReduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical tri...Stewart J. Tepper, Messoud Ashina, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H. Bonner, Hernan Picard, Sunfa Cheng, Denise E. Chou, Feng Zhang, Jan Klatt, Dani...> ;The Journal of Headache and Pain. 2021 Jul 23
- 9 citationsThe Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response.Gregor Broessner, Uwe Reuter, Jo H. Bonner, David W. Dodick, Yngve Hallstrom, Hernan Picard, Feng Zhang, Robert A. Lenz, Jan Klatt, Daniel D. Mikol> ;Headache. 2020 Oct 1
- 4 citationsEvaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraineVirginia L. Stauffer, Shufang Wang, Jo Bonner, ByungKun Kim, Rohit Bhandari, Kathleen Day, A. Camporeale> ;BMC Neurology. 2020 May 19
Press Mentions
Rural Health AdvocateSeptember 15th, 2021- UK Secures 90 Million COVID-19 Vaccine Doses; Germany Hotspot Numbers Four Times Previous EstimateAugust 15th, 2020
Theranica: New Publication Compares Remote Electrical Neuromodulation for Acute Treatment of Migraine to Treatment with Acute MedicationsJuly 24th, 2019
Hospital Affiliations
Mercy Hospital St. LouisSaint Louis, Missouri
